Carboxyamido-triazole Clinical Trials

Paid Clinical Trials > Browse Categories > Medications / Interventions > Cc > Carboxyamido-triazole

Carboxyamido-triazole

All Categories Medications / Interventions » Cc » Carboxyamido-triazole

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Conditions: Solid Tumors; Glioblastoma Multiforme; Recurrent Malignant Gliomas
Interventions: Drug: CTO; Drug: CTO and Temodar-R
Sponsors: Tactical Therapeutics, Inc.; Tactical Therapeutics, Inc.
Recruiting - verified October 2011

Main Menu

Clinical Trial Categories

Clinical Trial Locations

Sponsors/Recruiting

Join Clinical Trials

Patient Accounts| Sponsor Accounts | Paid Cliical Trials | Find Patients | Clinical Trail Jobs | Articles |Privacy Policy | Email Policy | Terms of Use | HIPPA |Contact Us | Sitemap
All information is pulled by the U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. Note: PaidClinicalTrials.org, paidclinicaltrials.org (Aunica Media llc) are resources that provide individuals with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free